136 related articles for article (PubMed ID: 9179267)
1. Proliferating cell nuclear antigen expression in the gallbladder with pancreaticobiliary maljunction.
Isozaki H; Okajima K; Hara H; Sako S; Mabuchi H
J Surg Oncol; 1997 May; 65(1):46-9. PubMed ID: 9179267
[TBL] [Abstract][Full Text] [Related]
2. A new model for pancreaticobiliary maljunction without bile duct dilatation: demonstration of cell proliferation in the gallbladder epithelium.
Kaneko K; Ando H; Umeda T; Murahashi O; Hiraiwa K; Niimi N; Hossain M; Ito T
J Surg Res; 1996 Jan; 60(1):115-21. PubMed ID: 8592401
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of 8-hydroxy-2'-deoxyguanosine in gallbladder epithelium of patients with pancreaticobiliary maljunction.
Otani K; Shimizu S; Chijiiwa K; Yamaguchi K; Noshiro H; Tanaka M
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1363-9. PubMed ID: 11692064
[TBL] [Abstract][Full Text] [Related]
4. Frequent expression of mucin core protein MUC1 in non-neoplastic gallbladder mucosa from patients with pancreaticobiliary maljunction.
Yamato T; Kurumaya H; Ohama K; Yamamichi N; Watanabe Y; Harada K; Sasaki M; Nakanuma Y
Liver; 1999 Aug; 19(4):281-7. PubMed ID: 10459625
[TBL] [Abstract][Full Text] [Related]
5. Studies on biliary tract carcinoma in the case with pancreaticobiliary maljunction.
Hara H; Morita S; Ishibashi T; Sako S; Dohi T; Otani M; Iwamoto M; Inoue H; Tanigawa N
Hepatogastroenterology; 2002; 49(43):104-8. PubMed ID: 11941930
[TBL] [Abstract][Full Text] [Related]
6. Increased cell proliferation and transforming growth factor-alpha (TGF alpha) in the gall-bladder epithelium of patients with pancreaticobiliary maljunction.
Kaneko K; Ando H; Ito T; Kasai K; Watanabe Y; Seo T
Pathol Int; 1996 Apr; 46(4):253-60. PubMed ID: 8726848
[TBL] [Abstract][Full Text] [Related]
7. Pathology and cellular kinetics of gallbladder with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Itoh M; Fujii K; Tsuchida A; Hirata M; Ishimaru S; Iwao T; Eguchi N; Kajiyama G
Am J Gastroenterol; 1996 May; 91(5):1007-11. PubMed ID: 8633539
[TBL] [Abstract][Full Text] [Related]
8. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of the gallbladder and anomalous arrangement of the pancreaticobiliary ductal system: cell kinetic studies of gallbladder epithelial cells.
Yang Y; Fujii H; Matsumoto Y; Suzuki K; Kawaoi A; Suda K
J Gastroenterol; 1997 Dec; 32(6):801-7. PubMed ID: 9430020
[TBL] [Abstract][Full Text] [Related]
10. Pathologic changes in the non-carcinomatous epithelium of the gallbladder in patients with a relatively long common channel.
Kamisawa T; Funata N; Hayashi Y; Egawa N; Nakajima H; Tsuruta K; Okamoto A; Yamaguchi T
Gastrointest Endosc; 2004 Jul; 60(1):56-60. PubMed ID: 15229426
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining of gallbladders from patients with pancreaticobiliary maljunction by antibody to proliferating cell nuclear antigen.
Kubota D; Kinoshita H; Hirohashi K; Kubo S; Fujio N; Iwasa R; Hamba H
Gastroenterol Jpn; 1992 Apr; 27(2):266. PubMed ID: 1349542
[No Abstract] [Full Text] [Related]
12. Significance of CD44s and CD44v6 expression in pancreaticobiliary maljunction.
Tsuchida A; Nagakawa Y; Kasuya K; Matudo T; Kyo B; Suzuki Y; Aoki T; Sato E; Nagao T; Itoi T
Hepatogastroenterology; 2011; 58(112):1877-81. PubMed ID: 22024057
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment for non-dilated biliary tract with pancreaticobiliary maljunction should include excision of the extrahepatic bile duct.
Hara H; Morita S; Ishibashi T; Sako S; Dohi T; Iwamoto M; Tanigawa N
Hepatogastroenterology; 2001; 48(40):984-7. PubMed ID: 11490854
[TBL] [Abstract][Full Text] [Related]
15. Biliary diverticulum with pancreaticobiliary maljunction.
Ikematsu Y; Eto T; Tomioka T; Matsumoto T; Tsunoda T; Kanematsu T
Hepatogastroenterology; 1994 Feb; 41(1):70-2. PubMed ID: 8175121
[TBL] [Abstract][Full Text] [Related]
16. The elevated mRNA content as a potential indicator of precancerous states of the gallbladder mucosa in patients with pancreaticobiliary maljunction.
Miura Y; Ichikawa Y; Ishikawa T; Sekido H; Nakano A; Mitsuhashi M; Shimada H
Oncol Rep; 1998; 5(4):845-51. PubMed ID: 9625830
[TBL] [Abstract][Full Text] [Related]
17. Liver, biliary and pancreatic injuries in pancreaticobiliary maljunction model in cats.
Chen F; Tang L; Zhang ZQ; Jin BW; Dong WF; Wang J; Huang SG
Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):90-5. PubMed ID: 25655296
[TBL] [Abstract][Full Text] [Related]
18. Adenomyomatosis of the Gallbladder With Pancreaticobiliary Maljunction in a Child.
Eda K; Mizuochi T; Takaki Y; Higashidate N; Hashizume N; Fukahori S; Asagiri K; Yamashita Y; Yagi M
J Pediatr Gastroenterol Nutr; 2018 Oct; 67(4):e82. PubMed ID: 30239487
[No Abstract] [Full Text] [Related]
19. Mucosal damage in pancreaticobiliary maljunction is stronger in the gallbladder than in the bile duct.
Kamakura M; Uehara T; Muraki T; Iwaya M; Asaka S; Nakajima T; Iwaya Y; Nagaya T; Yoshizawa T; Shimizu A; Kuraishi Y; Ota H; Umemura T
Pathol Res Pract; 2024 Jan; 253():155011. PubMed ID: 38103363
[TBL] [Abstract][Full Text] [Related]
20. Biliary carcinogenesis in pancreaticobiliary maljunction.
Kamisawa T; Kuruma S; Chiba K; Tabata T; Koizumi S; Kikuyama M
J Gastroenterol; 2017 Feb; 52(2):158-163. PubMed ID: 27704265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
